Early Identification and Treatment of Developmental Trochlear Femoral Dysplasia

Launched by JOAQUÍN MOYA-ANGELER PÉREZ-MATEOS · Oct 15, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a condition called developmental trochlear femoral dysplasia (DTFD), which can affect newborns, particularly those born in a breech position. The goal is to identify this condition early using ultrasound and to see if treating it with a modified Pavlik harness—similar to what is used for hip dysplasia—can improve the baby's condition. The trial is currently recruiting healthy newborns, both full-term and preterm (over 35 weeks), who were born breech. Babies with certain medical conditions, like cerebral palsy or chromosomal disorders, are not eligible to participate.

If your baby joins the study, they will receive either the treatment with the modified harness or will be monitored without the treatment for comparison. The trial includes regular check-ups at two weeks, eight weeks, and six months after enrollment to see how the treatment is working. This research aims to gather important information that could help improve early care for babies at risk of DTFD.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Healthy term and preterm newborns \> 35 weeks
• • Breech presentation at birth.
• Exclusion Criteria:
• • Infant cerebral palsy,
• • Developmental disorders
• • Chromosomal diseases.